Hui Wei

机构：Xuzhou Medical College, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Tianjin Anding Hospital, The First People's Hospital of Tianmen, Peking University Third Hospital, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0003-1674-3792

发表论文 199 篇 · 总被引 1965 次 · h-index 27

代表论文

• Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022 (2024 · Leukemia · 被引 43)
• Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022 (2025 · EClinicalMedicine · 被引 34)
• Selective translational control by PABPC1 phase separation regulates blast crisis and therapy resistance in chronic myeloid leukaemia (2025 · Nature Cell Biology · 被引 20)
• Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial (2025 · Leukemia · 被引 9)
• Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia (2024 · Cancer · 被引 8)
• Molecular imaging of fibroblast activation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study (2025 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 5)